U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06813573) titled 'Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma' on Jan. 22.
Brief Summary: The goal of this study is to prospectively follow the level of circulating nucleosomes in patients treated for a non-Hodgkin lymphoma and determine whether it correlates with the clinical response.
Study Start Date: Sept. 30, 2024
Study Type: INTERVENTIONAL
Condition:
Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Intervention:
BIOLOGICAL: blood sampling
A maximum of 4 tubes of 10ml will be collected: at baseline (before cycle 1), before each cycle (from 2 to 6 included), at the...